Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • 3 Questions With Robert Goulart, MD, MASCP

    Abstract Not Available
    Full Article
  • Oxidative Stress Levels and Dynamic Thiol-Disulfide Balance in Preterm Newborns with Bronchopulmonary Dysplasia

    Abstract Not Available
    Full Article
  • Incidental Finding of Parasitic Infection in a 75 Year Old Male with Persistent Hiccups

    Abstract Not Available
    Full Article
  • UN Issues Warning About Rising Infectious Diseases In Gaza

    The Hill (12/13, Nazzaro) reports, “The United Nations on Tuesday warned of rising infectious diseases in Gaza amid overcrowded living conditions and an overwhelmed health system as Israel continues to wage air and ground attacks against Palestinian militant group Hamas.” The UN Office for the Coordination of Humanitarian Affairs “pointed to the Gaza Health Ministry’s estimate of 360,000 cases of infectious diseases in shelters.” However, “a spokesperson for the Health Ministry, which is controlled by Hamas, said the actual number of cases is believed to be higher.”
    Full Article
  • Elevated Lp(a) Levels Linked To Greater Subclinical Interstitial Myocardial Fibrosis, Analysis Finds

    TCTMD (12/13, L. Maxwell) reports, “Elevated levels of lipoprotein(a) seem to be associated with greater subclinical interstitial myocardial fibrosis, increased myocardial scar prevalence, and left atrial remodeling by cardiac magnetic resonance, according to a new analysis.” The notion “that an elevated blood marker might be linked to fibrosis formation opens the door to potentially using Lp(a) to guide and develop treatment strategies for” patients with heart failure, “especially those who have heart failure with preserved ejection fraction, according to the authors.” The findings were published in the Journal of the American College of Cardiology.
    Full Article
  • mRNA-Based RSV Vaccine Effective For Older Adults, Study Finds

    MedPage Today (12/13, Kahn) reports, “Moderna’s mRNA-based RSV vaccine was effective at preventing RSV-associated lower respiratory tract disease in adults ages 60 and older, according to results of the randomized ConquerRSV trial.” The findings were published in the New England Journal of Medicine. Healio (12/13, Stulpin) also covers the story.
    Full Article
  • Immunocompromised Individuals Infected With COVID-19 Harbor SARS-CoV-2 Organisms With Higher Genetic Diversity, Study Finds

    Infectious Disease Advisor (12/13, Nye) reports, “Immunocompromised individuals infected with COVID-19 harbor SARS-CoV-2 organisms with higher genetic diversity, which may lead to the emergence of new variants,” according to a study. The findings were published in The Journal of Infectious Diseases.
    Full Article
  • Dengue Infections Reach New Record In Americas, Caribbean Amid Hotter Temperatures

    The AP (12/13, Coto) reports, “Dengue is sweeping across the Western Hemisphere in numbers not seen since record-keeping began more than four decades ago, with experts warning that rising temperatures and rapid urbanization are accelerating the pace of infections.” This year, “a record more than 4 million cases have been reported throughout the Americas and Caribbean ... surpassing a previous record set in 2019.” The rise can be attributed to “poor sanitation and a lack of robust health systems,” although “experts say droughts and floods linked to climate change are causing greater transmission of the virus.”
    Full Article
  • Flu Vaccine Efficacy During The 2022-2023 Influenza Season Was ‘Moderate’ But Still Prevented Many Hospitalizations Among Adult Patients, Study Indicates

    Healio (12/13, Stulpin) reports, “Influenza vaccine efficacy during the 2022-2023 influenza season was ‘moderate’ but still prevented many health care encounters and hospitalizations among adult patients, researchers determined.” The findings were published in The Journal Of Infectious Diseases.
    Full Article
  • One In Five Young Women With Germline BRCA Pathogenic Variants Able To Conceive Within 10 Years Of Invasive Breast Cancer Diagnosis, Study Finds

    MedPage Today (12/12, Swift) reports, “One in five young women with germline BRCA pathogenic variants were able to conceive within 10 years of invasive breast cancer diagnosis, and their pregnancies were not associated with adverse maternal prognosis or fetal outcomes, an international retrospective cohort study suggested.” The findings were published in JAMA. Healio (12/12, Welsh) also covers the story.
    Full Article
  • ColoSense Multitarget Stool RNA Test Demonstrated High Sensitivity For Detection Of Colorectal Cancer And Advanced Adenoma, Study Finds

    Healio (12/12, Burba) reports, “The ColoSense multitarget stool RNA test demonstrated high sensitivity for detection of colorectal cancer and advanced adenoma, notably in individuals aged 45 to 49 years, according to” a study. The findings were published in JAMA.
    Full Article
  • Despite mRNA-1273 Vaccination Association With Reduced Incidence Of COVID-19 Infection, Other Factors Beyond Vaccination Status May Influence Infection Risk, Study Finds

    Infectious Disease Advisor (12/12, Wei) reports, “Although mRNA-1273 vaccination is associated with reduced incidence of COVID-19 infection, other factors beyond vaccination status may influence infection risk,” according to a study. The findings were published in Open Forum Infectious Diseases.
    Full Article
  • B-Cell Depletion Therapy May Be Associated With Poor COVID-19 Outcomes, With Humoral Immune Response Impairment And T-Cell Hyperactivation As Primary Immunologic Features, Study Indicates

    Infectious Disease Advisor (12/12, Barowski) reports, “B-cell depletion therapy may be associated with poor COVID-19 outcomes, with humoral immune response impairment and T-cell hyperactivation as the primary immunologic features,” according to a recent study. The findings were published in Infectious Diseases.
    Full Article
  • AstraZeneca Purchases RSV Vaccine Developer In $1.1B Deal

    Reuters (12/12, Shabong) reports, “AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.” Icosavax is said to be “developing a combination vaccine candidate targeting RSV and human metapneumovirus.”
    Full Article
  • COVID-19 Hospitalizations, Deaths In Patients With SAIRDs Declined Significantly During The Most Recent Two Years Of The Pandemic, Study Indicates

    Healio (12/12, Martin) reports, “Hospitalizations and deaths due to COVID-19 in patients with [systemic] autoimmune rheumatic diseases declined significantly during the most recent 2 years of the pandemic, partly thanks to vaccination among vulnerable populations, according to data.” The findings were published in Clinical Rheumatology.
    Full Article
  • Supreme Court Dismisses Rulings On Vaccine Mandates For Federal Employees, Military Personnel

    The Hill (12/11, Schonfeld) reports, “The Supreme Court wiped a series of rulings implicating the Biden administration’s vaccine mandates for federal employees and military service members, preventing the decisions from holding the weight of precedent in the future.” In doing so, “the justices sided with the Biden administration Monday in agreeing to set aside the lower rulings after deeming the disputes moot, thus providing a clean legal slate for any future vaccine mandates.”
    Full Article
  • Biomarkers May Help Predict Remission Among Patients With Severe Asthma After Anti-IL-5 Therapy, Study Finds

    Healio (12/11, Hornick) reports, “Sputum neutrophil percentage and levels of eotaxin-1, IL-5 and eosinophil peroxidase may be used to predict remission among patients with severe asthma 1 year after anti-IL-5 therapy, according to a study.” Researchers found “sputum type 2 markers levels could be surrogate markers of response 1 year after anti-IL-5 treatment.” The findings were published in CHEST.
    Full Article
  • In Neonates With Acquired In Utero HIV Infection, Administration Of ART Within 48 Hours Of Life Can Lead To Sustained HIV Virological Suppression By Two Years, Study Finds

    MedPage Today (12/11, Kahn) reports, “In neonates with acquired in utero HIV infection, administration of antiretroviral therapy within 48 hours of life can lead to sustained HIV virological suppression by 2 years, a phase I/II proof-of-concept study indicated.” The findings were published in The Lancet HIV.
    Full Article
  • Study Finds Test-And-Treat Model For Hepatitis C Virus Infection Among Injection Drug Users, People Experiencing Homelessness Resulted In High Levels Of Treatment Initiation, Completion And Cure

    Healio (12/11, Burba) reports a study found “a test-and-treat model for hepatitis C virus infection among injection drug users and people experiencing homelessness resulted in high levels of treatment initiation, completion and cure, and may expand care access to marginalized groups.” The findings were published in JAMA Network Open.
    Full Article
  • Illumina Files Registration Statement Over Potential Divestiture Of Grail

    Reuters (12/11, Mishra) reports, “Illumina said on Monday it had filed a registration statement with the U.S. securities regulator related to a potential divestiture of Grail, even as it challenges a European Union order to divest the cancer test maker in court.” In October, Illumina “said it would divest Grail in 12 months, according to the terms of the European Commission’s order, if the life sciences company does not win its challenge in court.”
    Full Article
  • «
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id